Jobs / United States / Gilead Sciences INC
Associate Director, Medical Affairs
Gilead Sciences INC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles2 certified filings for “Associate Director, Patient Safety” (Medical and Health Services Managers) in CA: $209k–$226k, median $217k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet. Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows. Job Description We are seeking a Medical Strategy professional to join the Global Medical Strategy team for Lymphoma and Leukemia. This role partners closely with the Global Medical Lymphoma/Leukemia lead to support the development and execution of medical strategy across the product lifecycle, including marketed products and pipeline indications. The position collaborates cross‑functionally with internal partners and external experts to ensure the generation and communication of scientific evidence that supports optimal patient outcomes in hematologic malignancies. An exciting opportunity has arisen to join the Global Medical Strategy Team for Lymphoma and Leukemia (LL). In this role, the right candidate will receive a great opportunity to be part of one of the recent most impactful medical advancements in patient care and an opportunity to work towards better outcomes for patients with hematological malignancies. You will partner with the LL lead and be responsible for a range of key projects that are aligned to business needs. These could include but not be limited to strategic development and overall tactical execution of Medical Affairs activities related to the lifecycle management of the product & where relevant early and late-stage pipeline launch indications. You will collaborate cross-functionally with Clinical Development, HEOR, Market Access, Government Affairs, Marketing and in-function across different regions etc., as well as collaborate with external KOLs and decision-makers. This role will report to the Head of Global Medical Lymphoma/Leukemia Strategy and will work in partnership with them and the team to perform all aspects of the role. Key responsibilities • Partner within the Strategy Team to execute on required tasks and activities, deputizing for them when required • Execute on tactics such as advisory boards, publications, training etc. • Provide vision and direction for the assigned disease area, drive the development and execution of the cross-functional product and disease strategy • Partner with members of the extended Global Medical Affairs team such as RWE, Scientific Communication, Publications to provide input, direction and review of materials • Capture insights on the assigned therapy area systematically, both internal and external, and be able to translate these insights into actionable activities for the therapy area • Provide guidance for the development and execution of the disease strategy, the medical Plans of Action (POAs) and cross-functional projects • Participate in the exchange with the medical community and maintain a thought leader network • Collaborate effectively and in a compliant manner with colleagues in other functional areas, e.g. Clinical Research, Sales and Marketing, Market Access, PVE • Represent Global Medical Affairs to external and internal stakeholders, including groups of experts, medical professional groups, societies, regulatory gr